Amy Franke
Chief Tech/Sci/R&D Officer at SHATTUCK LABS, INC.
Amy Franke active positions
Companies | Position | Start | End |
---|---|---|---|
SHATTUCK LABS, INC. | Chief Tech/Sci/R&D Officer | 2022-09-30 | - |
Career history of Amy Franke
Former positions of Amy Franke
Companies | Position | Start | End |
---|---|---|---|
ARAVIVE, INC. | Chief Tech/Sci/R&D Officer | - | 2022-07-31 |
COVANCE INC. | Corporate Officer/Principal | - | - |
NERVGEN PHARMA CORP. | Chief Tech/Sci/R&D Officer | 2019-03-31 | - |
Training of Amy Franke
University of Michigan | Undergraduate Degree |
University of Pennsylvania Medical Center | Graduate Degree |
Statistics
International
United States | 6 |
Canada | 2 |
Operational
Chief Tech/Sci/R&D Officer | 3 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
SHATTUCK LABS, INC. | Health Technology |
NERVGEN PHARMA CORP. | Health Technology |
ARAVIVE, INC. | Health Technology |
Private companies | 1 |
---|---|
Labcorp Drug Development, Inc.
Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Amy Franke
- Experience